Table 1.
Clinical characteristics of patients (N = 18)
| Characteristic | N (%) |
|---|---|
| Sex (Male) | 13 (72.2) |
| Age (> 65 years) | 13 (72.2) |
| Department | |
| Respiratory | 5 (27.8) |
| Neurological | 4 (22.2) |
| ICU | 3 (16.7) |
| Neurosurgery | 3 (16.7) |
| Chinese traditional medicine | 1 (5.6) |
| Rehabilitation medicine | 1 (5.6) |
| Rheumatic immunology | 1 (5.6) |
| Specimen types | |
| Sputum | 15 (83.3) |
| Urine | 2 (11.1) |
| Blood | 1 (5.6) |
| ICU admission within 30 days before strain culture | 9 (50) |
| Blood transfusion within 30 days before strain culture | 3 (16.7) |
| Hospitalized for more than 14 days | 16 (88.9) |
| Underlying diseases | |
| Brain diseases | 17 (94.4) |
| Respiratory diseases | 17 (94.4) |
| Hypertension | 10 (55.6) |
| Heart diseases | 9 (50.0) |
| Diabetes | 3 (16.7) |
| Digestive system diseases | 3 (16.7) |
| Urinary system diseases | 3 (16.7) |
| Cancer | 2 (11.1) |
| Immune system diseases | 1 (5.6) |
| Complicated with fungal infection | 1 (5.6) |
| Treatment received before strain culture | |
| Multiple antibiotics | 14 (77.8) |
| β-lactamase inhibitors | 10 (55.6) |
| Carbapenems | 9 (50.0) |
| 3rd or 4th generation Cephalosporins | 7 (38.9) |
| Corticosteroids and immunosuppressants | 5 (27.8) |
| Quinolones | 5 (27.8) |
| Tetracyclines | 3 (16.7) |
| Polypeptides | 3 (16.7) |
| Aminoglycosides | 2 (11.1) |
| Invasive procedure within 90 days before strain culture | |
| Urinary catheter | 12 (66.7) |
| Tracheal intubation | 8 (44.4) |
| Mechanical ventilation | 7 (38.9) |
| Tracheostomy | 5 (27.8) |
| Arteriovenous catheterization | 3 (16.7) |